Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 8, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 8:15 a.m. PT (11:15 a.m. ET) in San Francisco, CA.
加州南舊金山，2025年1月8日 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.（納斯達克：RIGL）是一家專注於血液疾病和癌症的商業階段生物技術公司，今天宣佈，公司總統兼首席執行官Raul Rodriguez將於2025年1月16日（星期四）上午8:15（太平洋時間，11:15 東部時間）在加利福尼亞州舊金山舉行的第43屆J.P.摩根醫療健康大會上進行公司資料介紹。
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at . Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
要訪問直播網絡研討會或存檔錄音，請訪問公司網站的投資者關係部分。在直播網絡研討會開始前請連接到Rigel的網站，以便進行任何軟體下載。
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit .
關於Rigel
Rigel Pharmaceuticals, Inc.（納斯達克：RIGL）是一家致力於發現、開發和提供顯著改善血液疾病和癌症患者生活的新療法的生物技術公司。Rigel成立於1996年，總部位於加州南舊金山。有關Rigel、公司上市產品以及潛在產品管道的更多信息，請訪問。
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
[email protected]
投資者與媒體聯繫：
投資者：
Rigel Pharmaceuticals, Inc.
650.624.1232
[email protected]
Media:
David Rosen
Argot Partners
646.461.6387
[email protected]
媒體：
大衛·羅森
Argot Partners
646.461.6387
[email protected]
SOURCE Rigel Pharmaceuticals, Inc.
來源：Rigel Pharmaceuticals, Inc.
